Cargando…
Identification of Key miRNAs in the Treatment of Dabrafenib-Resistant Melanoma
Dabrafenib resistance is a significant problem in melanoma, and its underlying molecular mechanism is still unclear. The purpose of this study is to research the molecular mechanism of drug resistance of dabrafenib and to explore the key genes and pathways that mediate drug resistance in melanoma. G...
Autores principales: | Gao, Guangyu, Yao, Zhen, Shen, Jiaofeng, Liu, Yulong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046546/ https://www.ncbi.nlm.nih.gov/pubmed/33880366 http://dx.doi.org/10.1155/2021/5524486 |
Ejemplares similares
-
miRNAs as Key Players in the Management of Cutaneous Melanoma
por: Lorusso, Celeste, et al.
Publicado: (2020) -
Identification of lymph node metastasis-related microRNAs in breast cancer using bioinformatics analysis
por: Gao, Guangyu, et al.
Publicado: (2020) -
Dabrafenib for treatment of BRAF-mutant melanoma
por: Kainthla, Radhika, et al.
Publicado: (2013) -
Dabrafenib and its potential for the treatment of metastatic melanoma
por: Menzies, Alexander M, et al.
Publicado: (2012) -
The miRNAs Role in Melanoma and in Its Resistance to Therapy
por: Varrone, Francesca, et al.
Publicado: (2020)